A review on Nifedipine co-administered with Metoprolol succinate for the treatment of hypertension

  • Rajanit S
  • Dungrani M
  • Virani P
  • et al.
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Hypertension and Angina pectoris area major public health problem in the developed Countries recently. Hypertension and Angina Pectoris are frequently treated with antihypertensive drugs like calcium-channel blockers, angiotensin-converting enzyme inhibitors, and angiotensin II (AT1) receptor blockers, and statins. Nifedipine is calcium-channel blockers and widely used in treatment of Angina pectoris condition. Metoprolol Succinate is Beta-adrenoreceptor blocker and widely used in treatment of hypertension condition. Combination of Nifedipine and Metoprolol Succinate is used in the treatment of cardiovascular diseases like hypertension and Angina Pectoris. So this combination therapy gives antihypertensive and Angina Pectoris effects in the treatment of cardiac diseases.

Cite

CITATION STYLE

APA

Rajanit, S., Dungrani, M., Virani, P., & Raj, H. (2015). A review on Nifedipine co-administered with Metoprolol succinate for the treatment of hypertension. International Journal of Advances in Scientific Research, 1(3), 129. https://doi.org/10.7439/ijasr.v1i3.1795

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free